Enhabit Home Health & Hospice Announces Date of 2023 Third Quarter Earnings Call; Comments on Limited Waiver and Liquidity
05 October 2023 - 7:41AM
Business Wire
Enhabit, Inc. (NYSE: EHAB), a leading national home health and
hospice provider, today provided updates on the timing for release
of its results for the third quarter ended Sept. 30, 2023, and
certain other matters.
The Company is in the process of closing its books for the third
quarter ended Sept. 30, 2023, and will report its results on Nov.
7, 2023, and host a webcast and conference call on Nov. 8, 2023.
Individuals who would like to participate in the conference call
webcast should join 15 minutes before the scheduled start time.
- Nov. 8, 2023
- 10:00 a.m. Eastern
- Toll-free: 888-660-6150
- International: 929-203-0843
- Conference ID: 5248158
- Internet website:
https://events.q4inc.com/attendee/923162031
A link to the webcast of the conference call and online replay
can be found on Enhabit’s investor website.
Other information
As previously announced on a Form 8-K filed on Oct. 2, 2023, the
Company entered into a Limited Waiver dated Sept. 29, 2023, with
Wells Fargo Bank, National Association, as administrative agent
under its existing Credit Agreement. Also as previously announced,
Enhabit has launched a process to review strategic alternatives.
Since the announcement, the Company has been working diligently
with its advisors on this review process, and the process is
ongoing. With respect to the Limited Waiver announced in the Form
8-K, Company President and Chief Executive Officer Barb Jacobsmeyer
said, “As we work with our advisors and prospective strategic
partners as part of our strategic review, out of an abundance of
caution we chose to proactively reach out to our bank group to
ensure we remain in compliance with our financial covenants.” At
this time, the Company believes it has adequate liquidity. The
Company has not drawn on its revolving credit facility in 2023. As
of Sept. 30, 2023, the Company had total available liquidity of
approximately $80 million, including cash and cash equivalents.
About Enhabit Home Health & Hospice
Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading
national home health and hospice provider working to expand what’s
possible for patient care in the home. Enhabit’s team of clinicians
supports patients and their families where they are most
comfortable, with a nationwide footprint spanning 255 home health
locations and 108 hospice locations across 34 states. Enhabit
leverages advanced technology and compassionate teams to deliver
extraordinary patient care. For more information, visit
ehab.com.
Forward-looking statements
Statements contained in this press release which are not
historical facts, such as those relating to the status of our
strategic alternatives review process and our current liquidity
position and other future events are forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. All forward-looking information speaks only as of the date
hereof, and Enhabit undertakes no duty to publicly update or revise
such forward-looking information, whether as a result of new
information, future events, or otherwise. Such forward-looking
statements are based upon current information and involve a number
of risks and uncertainties. Actual events or results may differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors. While it is
impossible to identify all such factors, factors which could cause
actual events or results to differ materially from our present
expectations include, but are not limited to, our ability to
execute on our strategic plans, regulatory and other developments
impacting the markets for our services, changes in reimbursement
rates, general economic conditions, our ability to attract and
retain key management personnel and healthcare professionals,
potential disruptions or breaches of our or our vendors’
information systems, the outcome of litigation, our ability to
successfully complete and integrate de novo developments,
acquisitions, investments, and joint ventures, our ability to
control costs, particularly labor and employee benefit costs and
our ability to successfully pursue and complete a strategic
transaction. Our Form 10-K and subsequent quarterly reports on Form
10-Q, each of which can be found on the Company’s website at
http://investors.ehab.com and the SEC’s website at www.sec.gov,
discuss other risks and factors that could cause actual results to
differ materially from those expressed or implied by any
forward-looking statement in this press release. We urge you to
consider all of the risks, uncertainties and factors identified
above or discussed in such reports carefully in evaluating the
forward-looking statements in this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231004765575/en/
Investor relations contact Jordan Loyd
investorrelations@ehab.com 469-860-6061
Media contact Erin Volbeda media@ehab.com
972-338-5141
Enhabit (NYSE:EHAB)
Historical Stock Chart
From Apr 2024 to May 2024
Enhabit (NYSE:EHAB)
Historical Stock Chart
From May 2023 to May 2024